Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apollo Medco
Atlanta, Georgia, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Apollo Medco developed a mobile, cloud-connected COVID-19 rapid antigen testing platform capable of processing 200-300 people per hour, promising 15-minute results and real-time reporting; status after 2021 is unknown
- Therapeutic areas
- Infectious Diseases
- Modalities
- DeviceDiagnostic platform
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
Used test kits from QuidelUsed test kits from BDUsed test kits from Abbott
Beyond the preview
Go deeper on Apollo Medco.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Apollo Medco.